|
KMID : 1155520080030040255
|
|
Anesthesia and Pain Medicine
2008 Volume.3 No. 4 p.255 ~ p.259
|
|
|
Association of 5-HT3A receptor Pro16Ser polymorphism with the incidence of PONV and the response to ondansetron in Korean patients
|
|
Goo Eui-Kyoung
Jang In-Jin
Jeon Young-Tae
Hwang Jung-Won
Song Eun
Do Sang-Hwan
So Yun-Mi
Ryu Jung-Hee
|
|
|
Abstract
|
|
|
Backgound: Postopertative nausea and vomiting (PONV) are frequent and distressing side effects of surgery. Even though many drugs has been developed, PONV still remains unsolved problem. Ondansetron is a commonly used 5-HT3 receptor antagonist. It acts through specific binding to the 5-HT3A, 5-HT3B receptor complex. We hypothesized that patients with genetic variation in 5-HT3A receptor might have variable incidence of PONV and respond differently to ondansetron.
Methods: We included 204 patients undergoing gynecologic laparoscopic surgery. PONV were documented during 24 hours after operation. Ondansetron was injected to every patient who had PONV at PACU and PONV reassessed after 15 minutes. DNA was extracted from blood and 5-HT3A Pro16Ser missense mutation was analyzed by using real-time PCR.
Results: The incidence of PONV were 50% for wild type, 53% for heterozygote and 0% for homozygote. There were no significant differences between wild type and heterozygote in VAS of nausea and VAS change after ondansetron.
Conclusions: 5-HT3A receptor Pro16Ser polymorphism is not associated with the incidence of PONV and the response to ondansetron in Korean patients. (Anesth Pain Med 2008; 3: 255∼259)
|
|
|
KEYWORD
|
|
|
5-HT3A receptor, ondansetron, polymorphism, PONV, Pro16Ser
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|